Establishment and evaluation of rat model of type 2 diabetes with liver fibrosis
Author:
Affiliation:

1. Laboratory Animal Center, Fujian Medical University, Fuzhou 350004, China; 2. the United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350028, China

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective To establish a rat model of type 2 diabetes mellitus with hepatic fibrosis using a highlipid-sugar diet (HLSD) combined with inducement with carbon tetrachloride (CCl4 ) and streptozotocin. Methods SD rats were randomly divided into a liver fibrosis (LF) group, type 2 diabetes combined with liver fibrosis (DLF) group, and normal group, with 10 rats in each group. All rats in the LF or DLE group were fed an HLSD for 4 weeks; then, all rats were intraperitoneally injected with 20% CCl4 (once a week) according to body weight (5 mL/kg) to induce hepatic fibrosis for another 4 weeks. During CCl4 treatment, rats in the DLF

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:36
  • PDF: 28
  • HTML: 0
  • Cited by: 0
History
  • Received:May 30,2024
  • Online: April 10,2025
Article QR Code